These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7685797

  • 1. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
    Haziot A, Tsuberi BZ, Goyert SM.
    J Immunol; 1993 Jun 15; 150(12):5556-65. PubMed ID: 7685797
    [Abstract] [Full Text] [Related]

  • 2. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
    Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Jun 01; 148(11):3505-12. PubMed ID: 1375247
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF, Dentener MA, Buurman WA.
    J Immunol; 1994 May 15; 152(10):5070-6. PubMed ID: 7513728
    [Abstract] [Full Text] [Related]

  • 4. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ.
    J Immunol; 1993 Apr 01; 150(7):3011-21. PubMed ID: 7681085
    [Abstract] [Full Text] [Related]

  • 5. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
    J Lab Clin Med; 1995 May 01; 125(5):662-71. PubMed ID: 7537790
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A, de Graaf-Miltenburg LA, van Bommel T, Verhoef J, Van Kessel KP, Van Strijp JA.
    J Immunol; 1999 Apr 01; 162(7):4220-5. PubMed ID: 10201950
    [Abstract] [Full Text] [Related]

  • 7. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
    Camussi G, Mariano F, Biancone L, De Martino A, Bussolati B, Montrucchio G, Tobias PS.
    J Immunol; 1995 Jul 01; 155(1):316-24. PubMed ID: 7541418
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.
    Hailman E, Vasselon T, Kelley M, Busse LA, Hu MC, Lichenstein HS, Detmers PA, Wright SD.
    J Immunol; 1996 Jun 01; 156(11):4384-90. PubMed ID: 8666811
    [Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide primes human basophils for enhanced mediator release: requirement for plasma co-factor and CD14.
    Iida M, Hirai K, Shinohara S, Yamaguchi M, Takaishi T, Sakamoto Y, Ito K, Morita Y.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1295-301. PubMed ID: 7522445
    [Abstract] [Full Text] [Related]

  • 10. Moesin: a potential LPS receptor on human monocytes.
    Amar S, Oyaisu K, Li L, Van Dyke T.
    J Endotoxin Res; 2001 Sep 15; 7(4):281-6. PubMed ID: 11717582
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
    Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA.
    J Immunol; 1993 Apr 01; 150(7):2885-91. PubMed ID: 7681082
    [Abstract] [Full Text] [Related]

  • 12. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14.
    Weinstein SL, June CH, DeFranco AL.
    J Immunol; 1993 Oct 01; 151(7):3829-38. PubMed ID: 7690817
    [Abstract] [Full Text] [Related]

  • 13. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
    Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP, Heumann D.
    J Immunol; 1993 Jun 01; 150(11):5086-93. PubMed ID: 7684419
    [Abstract] [Full Text] [Related]

  • 14. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood.
    Haziot A, Rong GW, Bazil V, Silver J, Goyert SM.
    J Immunol; 1994 Jun 15; 152(12):5868-76. PubMed ID: 7515917
    [Abstract] [Full Text] [Related]

  • 15. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
    Theofan G, Horwitz AH, Williams RE, Liu PS, Chan I, Birr C, Carroll SF, Mészáros K, Parent JB, Kasler H.
    J Immunol; 1994 Apr 01; 152(7):3623-9. PubMed ID: 7511654
    [Abstract] [Full Text] [Related]

  • 16. [Lipopolysaccharide binding protein enhances intratracheally administrated lipopolysaccharide-induced acute lung inflammation via a CD14 receptor].
    Ishii Y, Kitamura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec 01; 30 Suppl():225-31. PubMed ID: 1284855
    [Abstract] [Full Text] [Related]

  • 17. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
    Gessani S, Testa U, Varano B, Di Marzio P, Borghi P, Conti L, Barberi T, Tritarelli E, Martucci R, Seripa D.
    J Immunol; 1993 Oct 01; 151(7):3758-66. PubMed ID: 7690813
    [Abstract] [Full Text] [Related]

  • 18. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.
    Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P.
    Eur J Immunol; 1993 Sep 01; 23(9):2144-51. PubMed ID: 7690322
    [Abstract] [Full Text] [Related]

  • 19. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
    Haziot A, Rong GW, Silver J, Goyert SM.
    J Immunol; 1993 Aug 01; 151(3):1500-7. PubMed ID: 7687634
    [Abstract] [Full Text] [Related]

  • 20. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
    Bjerre A, Brusletto B, Øvstebø R, Joø GB, Kierulf P, Brandtzaeg P.
    J Endotoxin Res; 2003 Aug 01; 9(3):155-63. PubMed ID: 12831456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.